Host-mediated Leishmania donovani treatment using AR-12 encapsulated in acetalated dextran microparticles

Leishmaniasis is a disease caused by parasites of Leishmania sp., which effects nearly 12 million people worldwide and is associated with treatment complications due to widespread parasite resistance toward pathogen-directed therapeutics. The current treatments for visceral leishmaniasis (VL), the s...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Pharm
Hlavní autoři: Collier, M.A., Peine, K.J., Gautam, S., Oghumu, S., Varikuti, S., Borteh, H., Papenfuss, T.L., Sataoskar, A.R., Bachelder, E.M., Ainslie, K.M.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5730989/
https://ncbi.nlm.nih.gov/pubmed/26768723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpharm.2016.01.004
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky